Results 51 to 60 of about 17,861,189 (258)

Flow chart of the computation process for lifetime costs and cost-per-QALY (quality-adjusted life year).

, 2012
Flow chart of the computation process for lifetime costs and cost-per-QALY (quality-adjusted life year).
Likwang Chen (111860), Cheng-Ren Chen (136899), Ming-Shian Lin (136896), Hsin-Ming Lu (111855), Mei-Chuan Hung (136892), Jung-Der Wang (66748), Chong-Jen Yu (58765)   +6 more
core   +1 more source

Impact of Initial Treatment Setting on Survival in Relapsed Pediatric and AYA Bone Sarcomas: A Secondary Analysis of a Prospective Clinical Trial

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak, Katarzyna Bilska, Tomasz Koziński, Jadwiga Węcławek‐Tompol, Dorota Sega‐Pondel, Radosław Chaber, Wanda Badowska, Katarzyna Rosłan, Hanna Koseła‐Paterczyk, Anna Raciborska   +9 more
wiley   +1 more source

ESTIMATING QALYS IN THE WESTERN REGION OF ROMANIA – THE CASE WITH INTERVENTION [PDF]

Annals of the University of Oradea: Economic Science, 2013
Currently, we are in the process of experimenting a diversification and refinement of the consumer’s expectations, as well as a growing demand for innovative, quality products and customized services, exacerbated by rapid technological change affecting
Pantea Marius, Gligor Delia, ,
doaj  

Crude and adjusted beta-coefficients for the association between resilience levels and quality of life perception.

, 2015
Results presented as beta-coefficients (95%confidence intervals); Adjusted models are adjusted for sex, age, year of medical course, presence of a BDI score ≥ 10 points and presence of marked anxiety symptoms (state or trait). QoL = Quality of life.Crude
Nilson R. Silva (762543), Paulo S. P. Silveira (547690), Munique Peleias (762539), Bruno Perotta (547691), Helena B. M. S. Paro (547689), Milton A. Martins (3264867), Fernanda B. Mayer (762538), Vera Lucia Garcia (762540), Silmar Gannam (547692), Patricia Tempski (762536), Sylvia C. Enns (547693), Emirene M. T. Navarro da Cruz (762544), Katia B. Guimaraes (762542), Luis F. Tofoli (693446), Itamar S. Santos (762537), Sergio Baldassin (762541)   +15 more
core   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa, Kyomi Kanaya, Kiyomi Aizawa, Masanori Onoki, Hirofumi Ozeki, Kazuko Suzuki, Ai Hayashi, Tomohiko Asamura   +7 more
wiley   +1 more source

Design and analysis strategies for robust microbiome ageing research

FEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik, İsmail Güderer, Yi Wang, Tayyaba Alvi, Prasoon Pandey, Handan Melike Dönertaş   +5 more
wiley   +1 more source

Combination method to estimate willingness to pay per quality-adjusted life year.

Combination method to estimate willingness to pay per quality-adjusted life year.
Klas Göran Sahlen (17935584), Lars Lindholm (21685), Anh Nu Vu (17935581), Minh Van Hoang (6842081), Cuc Thi Thu Nguyen (14059662), Sun Sun (15469762)   +5 more
core   +1 more source

Exempt_Consent_copy_ – Supplemental material for Quality-adjusted life year weights and treatment bias: Theory and evidence from cognitive interviews

, 2019
Supplemental material, Exempt_Consent_copy_ for Quality-adjusted life year weights and treatment bias: Theory and evidence from cognitive interviews by Bryan N Patenaude and Till Bärnighausen in SAGE Open ...
Bryan N Patenaude (6835328), Till Bärnighausen (36281)   +1 more
core   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Long-term cost-effectiveness of ticagrelor versus clopidogrel in acute coronary syndrome in Spain [PDF]

Farmacia Hospitalaria, 2014
Objective: To assess the cost-effectiveness relationship of Ticagrelor versus Clopidogrel for the management of acute coronary syndrome in Spain. Methods: The data from the PLATO study were used for the calculation of the events rate and health-related
E. Molina-Cuadrado, H. Mateo-Carrasco, P. Nieto-Guindo, P. Rodríguez-Gómez   +3 more
doaj   +1 more source